Status:

COMPLETED

Studying Students at Risk for COVID-19

Lead Sponsor:

University of Michigan

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this longitudinal observational study is to learn about how the COVID-19 has impacted and continues to impact students at the University of Michigan. We hope to determine whether a combina...

Detailed Description

The study was originally intended to last one year, however, it was expanded to follow the study participants over several years. During this study, participants will be asked to: * Provide a baseli...

Eligibility Criteria

Inclusion

  • Students at the University of Michigan who have moved back to Ann Arbor or who are completing schooling completely online.
  • For those completing school online, must be able to provide a mailing address within the United States where they can receive study tools
  • Possession of a smartphone (Apple or Andriod)
  • Ability to understand and demonstrate willingness to sign a written informed consent.

Exclusion

  • Unwilling or unable to comply with the study procedures.

Key Trial Info

Start Date :

September 3 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 18 2023

Estimated Enrollment :

2381 Patients enrolled

Trial Details

Trial ID

NCT04766788

Start Date

September 3 2020

End Date

April 18 2023

Last Update

December 29 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Michigan Medicine

Ann Arbor, Michigan, United States, 48109